These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 34079441)

  • 21. ALDH1A1 regulates postsynaptic μ-opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling.
    Pan J; Yu J; Sun L; Xie C; Chang L; Wu J; Hawes S; Saez-Atienzar S; Zheng W; Kung J; Ding J; Le W; Chen S; Cai H
    Sci Rep; 2019 Mar; 9(1):3602. PubMed ID: 30837649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution, connection and function of ALDH1A1
    Liu H; Gong Z; Li Z; Ye T; Cao A; He S; Lin S; Duan J; Lin X
    Neurosci Lett; 2024 Jan; 818():137555. PubMed ID: 37972684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.
    Drui G; Carnicella S; Carcenac C; Favier M; Bertrand A; Boulet S; Savasta M
    Mol Psychiatry; 2014 Mar; 19(3):358-67. PubMed ID: 23399912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.
    Serra M; Pinna A; Costa G; Usiello A; Pasqualetti M; Avallone L; Morelli M; Napolitano F
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070217
    [No Abstract]   [Full Text] [Related]  

  • 27. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cortical Pathogenic Theory of Parkinson's Disease.
    Foffani G; Obeso JA
    Neuron; 2018 Sep; 99(6):1116-1128. PubMed ID: 30236282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.
    Shehadeh J; Double KL; Murphy KE; Bobrovskaya L; Reyes S; Dunkley PR; Halliday GM; Dickson PW
    Neurobiol Dis; 2019 Oct; 130():104524. PubMed ID: 31276794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism.
    Dodson PD; Dreyer JK; Jennings KA; Syed EC; Wade-Martins R; Cragg SJ; Bolam JP; Magill PJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2180-8. PubMed ID: 27001837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson's Disease.
    Struzyna LA; Browne KD; Burrell JC; Vélez WJG; Wofford KL; Kaplan HM; Murthy NS; Chen HI; Duda JE; España RA; Cullen DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease.
    Escande MV; Taravini IR; Zold CL; Belforte JE; Murer MG
    J Neurosci; 2016 May; 36(21):5686-98. PubMed ID: 27225760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective A
    Fathalla AM; Soliman AM; Moustafa AA
    Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
    Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
    Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.